JAK2 Inhibitors: Are They the Solution?
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2011.02.007
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2011
Authors
Publisher
Elsevier BV
Available in full text
June 1, 2011
Elsevier BV